Table 4. Multivariate analysis of 5 year survival rates after hyperthermo-chemoradiotherapy (HCRT).

Factors	OS		LC		DMFS
	HR (95% CI)	P-value	HR (95% CI)	P-value	HR (95% CI)	P-value
Age (<60 or≥60)	0.82 (0.20–3.30)	0.79	1.18 (0.10–13.49)	0.89	0.93 (0.25–3.45)	0.92
Gender	0.86 (0.39–1.91)	0.72	0.00 (0.0–4.73E+135)	0.97	1.21 (0.61–2.41)	0.58
HLA class I (post-HCRT)	4.62 (0.57–37.47)	0.15	0.00 (0.0–7.68E+232)	0.96	2.26 (0.46–11.03)	0.31

OS, overall survival; LC, local control; DMFS, distant metastasis-free survival; CI, confidence interval; HLA, human leukocyte antigen; HR, Hazard ratio.